Drug search by name

Pharmorubicin Pfs and Neutropenia

Result of checking the interaction of drug Pharmorubicin Pfs and disease Neutropenia for safety when used together.

Check result:

Pharmorubicin Pfs <> Neutropenia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Patients should not be treated with epirubicin if they have a baseline neutrophil count < 1500 cells/mm3. A dose-dependent, reversible leukopenia and/or neutropenia is the predominant manifestation of hematologic toxicity associated with epirubicin and represents the most common acute dose-limiting toxicity of this drug. Myelosuppression requires careful monitoring. Total and differential WBC, red blood cell (RBC), and platelet counts should be assessed before and during each cycle of therapy with epirubicin.

Pharmorubicin Pfs

Generic Name: epirubicin

Brand Name: Ellence, Pharmorubicin Pfs, Pharmorubicin RDF

Synonyms: Pharmorubicin Pfs (Intravenous)

What is Pharmorubicin Pfs?